Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance.
- NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_assertion description "[Employing EGFR inhibition with erlotinib specifically at this premalignant stage was effective in decreasing the incidence of ER-negative breast tumors in this mouse model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance.
- NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_assertion evidence source_evidence_literature NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance.
- NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_assertion SIO_000772 21396117 NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance.
- NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_assertion wasDerivedFrom befree-20140225 NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance.
- NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_assertion wasGeneratedBy ECO_0000203 NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance.
- befree-20140225 importedOn "2014-02-25" NP762999.RA235PPyqnfgv3Q0ZeB2-0k_WhNBBzOfEnK6FW5sWdT8w130_provenance.